Annual report pursuant to Section 13 and 15(d)

Acquisitions - Schedule of Allocation of Purchase Price (Details)

v3.20.1
Acquisitions - Schedule of Allocation of Purchase Price (Details) - USD ($)
 3 Months Ended 12 Months Ended
Feb. 16, 2018
Nov. 17, 2017
Sep. 30, 2018
Jun. 30, 2018
Dec. 31, 2018
Dec. 31, 2019
Dec. 31, 2017
Fair value of liabilities assumed:              
Debt assumed in Avadel Pediatric Products acquisition         $ (15,075,000) $ 0  
Goodwill         14,409,088 $ 14,409,088 $ 12,290,247
Measurement Period Adjustments              
Intangible assets         6,000    
Goodwill         $ (1,659,160)    
Avadel              
Fair value of assets acquired:              
Inventory $ 718,000            
Prepaid expenses and other current assets 570,000            
Identifiable Intangible Assets:              
Intangible assets 18,291,000            
Fair value of liabilities assumed:              
Accrued expenses and other current liabilities (362,000)            
Debt assumed in Avadel Pediatric Products acquisition (15,075,000)            
Fair value of contingent consideration (7,920,000)            
Total identifiable net assets (3,778,000)            
Fair value of consideration transferred 1            
Goodwill 3,778,001            
Measurement Period Adjustments              
Inventory       $ (1,831,000)      
Prepaid assets       570,000      
Intangible assets       1,838,000      
Accrued expenses       (362,000)      
Fair value of debt assumed       197,303      
Fair value of contingent consideration       (44,835)      
Total net liabilities assumed       367,468      
Consideration exchanged       (240,999)      
Goodwill       $ (608,467)      
TRx              
Fair value of assets acquired:              
Cash and cash equivalents   $ 11,068          
Accounts receivable, net   2,872,545          
Inventory   495,777          
Prepaid expenses and other current assets   134,281          
Other receivables   2,764,515          
Identifiable Intangible Assets:              
Intangible assets   19,596,000          
Total assets acquired   25,874,186          
Fair value of liabilities assumed:              
Accounts payable   192,706          
Accrued expenses and other current liabilities   (8,614,937)          
Deferred tax liability   918,613          
Total liabilities assumed   9,726,256          
Total identifiable net assets   16,147,930          
Fair value of consideration transferred   28,781,052          
Goodwill   12,633,122          
Measurement Period Adjustments              
Accounts receivable, net     $ 0        
Inventory     0        
Prepaid assets     0        
Other receivables     2,764,515        
Intangible assets     1,528,000        
Total assets acquired     4,292,515        
Accounts payable     0        
Accrued expenses     (3,764,515)        
Deferred tax liability     78,840        
Fair value of contingent consideration     1,210,000        
Total liabilities assumed     3,843,355        
Total net liabilities assumed     449,160        
Consideration exchanged     (1,210,000)        
Goodwill     (1,659,160)        
PAI Sales & Marketing Agreement | TRx              
Identifiable Intangible Assets:              
Intangible assets   2,553,000          
Measurement Period Adjustments              
Intangible assets     219,000        
Metafolin | Acquired Product Marketing Rights | TRx              
Identifiable Intangible Assets:              
Intangible assets   11,987,000          
Measurement Period Adjustments              
Intangible assets     1,522,000        
Millipred | Acquired Product Marketing Rights | TRx              
Identifiable Intangible Assets:              
Intangible assets   5,056,000          
Measurement Period Adjustments              
Intangible assets     342,000        
Ulesfia | Acquired Product Marketing Rights | TRx              
Identifiable Intangible Assets:              
Intangible assets   0          
Measurement Period Adjustments              
Intangible assets     $ (555,000)        
Previously Reported | Avadel              
Fair value of assets acquired:              
Inventory 2,549,000            
Prepaid expenses and other current assets 0            
Identifiable Intangible Assets:              
Intangible assets 16,453,000            
Fair value of liabilities assumed:              
Accrued expenses and other current liabilities 0            
Debt assumed in Avadel Pediatric Products acquisition (15,272,303)            
Fair value of contingent consideration (7,875,165)            
Total identifiable net assets (4,145,468)            
Fair value of consideration transferred 241,000            
Goodwill $ 4,386,468            
Previously Reported | TRx              
Fair value of assets acquired:              
Cash and cash equivalents   11,068          
Accounts receivable, net   2,872,545          
Inventory   495,777          
Prepaid expenses and other current assets   134,281          
Other receivables   0          
Identifiable Intangible Assets:              
Intangible assets   18,068,000          
Total assets acquired   21,581,671          
Fair value of liabilities assumed:              
Accounts payable   192,706          
Accrued expenses and other current liabilities   (4,850,422)          
Deferred tax liability   839,773          
Total liabilities assumed   5,882,901          
Total identifiable net assets   15,698,770          
Fair value of consideration transferred   29,991,052          
Goodwill   14,292,282          
Previously Reported | PAI Sales & Marketing Agreement | TRx              
Identifiable Intangible Assets:              
Intangible assets   2,334,000          
Previously Reported | Metafolin | Acquired Product Marketing Rights | TRx              
Identifiable Intangible Assets:              
Intangible assets   10,465,000          
Previously Reported | Millipred | Acquired Product Marketing Rights | TRx              
Identifiable Intangible Assets:              
Intangible assets   4,714,000          
Previously Reported | Ulesfia | Acquired Product Marketing Rights | TRx              
Identifiable Intangible Assets:              
Intangible assets   $ 555,000